Once-weekly insulin for type 2 diabetes without previous insulin treatment
Rosenstock J, Bajaj HS, Janež A, et al.
N Engl J Med. Pub.online 22 September 2020
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Cardiovascular outcomes with ertugliflozin in type 2 diabetes
Cannon CP, Pratley R, Dagogo-Jack S, et al.
N Engl J Med. Pub. online 23 September 2020
Leggi
Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for covid-19: the Pisa COVID-19 Study
Coppelli A, Giannarelli R, Aragona M, et al.
Diabetes Care. 2020;43(10):2345-48
Leggi
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Filion KB, Lix LM, Yu OHY, et al.
BMJ. 2020;370:m3342
Leggi
Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies
Jayedi A, Soltani S, Zargar MS, et al.
BMJ. 2020;370:m3324
Leggi
Dapagliflozin in patients with chronic kidney disease
Heerspink HJL, Stefànsson BV, Correa-Rotter R, et al.
N Engl J Med. Pub. online 24 September 2020
Leggi
Determinants of good metabolic control without weight gain in type 2 diabetes management: a machine learning analysis
Giorda CB, Pisani F, De Micheli A, Ponzani P, Russo G, Guaita G, Zilich R, Musacchio N; Associazione Medici Diabetologi (AMD) Annals Study Group
BMJ Open Diabetes Res Care. 2020;8(1):e001362
Leggi
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials
Groop P-H, Dandona P, Phillip M, et al.
The Lancet Diabetes & Endocrinology. 2020;8(10):845-54
Leggi
Diabetes in ageing: pathways for developing the evidence base for clinical guidance
Munshi MN, Meneilly GS, Rodríguez-Mañas L, et al.
The Lancet Diabetes & Endocrinology. 2020;8(10):855-86
Leggi
Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial
Feig DS, Donovan LE, Zinman B, et al.
The Lancet Diabetes & Endocrinology. 2020;8(10):834-44
Leggi